<<Previous Next>>
Response    Page 1 of 1    (749 of 749 records)
# DataId Indicator Value Precision DHS_CountryCode CountryName SurveyYear SurveyId IndicatorId IndicatorOrder IndicatorType CharacteristicId CharacteristicOrder CharacteristicCategory CharacteristicLabel ByVariableId ByVariableLabel IsTotal IsPreferred SDRID RegionId SurveyYearLabel SurveyType DenominatorWeighted DenominatorUnweighted CILow CIHigh LevelRank
1 10558 SP/Fansidar use during pregnancy 4.7 1 AO Angola 2006 AO2006MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006-07 MIS 1015 1095      
2 10559 SP/Fansidar 2+ doses during pregnancy 2.8 1 AO Angola 2006 AO2006MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006-07 MIS 1015 1095      
3 10557 SP/Fansidar 3+ doses during pregnancy 1.5 1 AO Angola 2006 AO2006MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006-07 MIS 1015 1095      
4 10560 SP/Fansidar use during antenatal visit 4.1 1 AO Angola 2006 AO2006MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006-07 MIS 1015 1095      
5 10561 SP/Fansidar 2+ doses, at least one during ANC visit 2.4 1 AO Angola 2006 AO2006MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006-07 MIS 1015 1095      
6 10562 SP/Fansidar 3+ doses, at least one during ANC visit 1.4 1 AO Angola 2006 AO2006MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006-07 MIS 1015 1095      
7 197478 SP/Fansidar use during pregnancy 30.1 1 AO Angola 2011 AO2011MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 MIS 3096 3120      
8 197479 SP/Fansidar 2+ doses during pregnancy 18.6 1 AO Angola 2011 AO2011MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 MIS 3096 3120      
9 197486 SP/Fansidar 3+ doses during pregnancy 8.4 1 AO Angola 2011 AO2011MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 MIS 3096 3120      
10 197483 SP/Fansidar use during antenatal visit 28.3 1 AO Angola 2011 AO2011MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 MIS 3096 3120      
11 197484 SP/Fansidar 2+ doses, at least one during ANC visit 17.5 1 AO Angola 2011 AO2011MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 MIS 3096 3120      
12 197485 SP/Fansidar 3+ doses, at least one during ANC visit 7.9 1 AO Angola 2011 AO2011MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 MIS 3096 3120      
13 436545 SP/Fansidar use during pregnancy 55.9 1 AO Angola 2015 AO2015DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015-16 DHS 5405 5837      
14 436547 SP/Fansidar 2+ doses during pregnancy 38.4 1 AO Angola 2015 AO2015DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015-16 DHS 5405 5837      
15 436546 SP/Fansidar 3+ doses during pregnancy 20 1 AO Angola 2015 AO2015DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015-16 DHS 5405 5837      
16 436571 SP/Fansidar use during antenatal visit 53.9 1 AO Angola 2015 AO2015DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015-16 DHS 5405 5837      
17 436572 SP/Fansidar 2+ doses, at least one during ANC visit 36.8 1 AO Angola 2015 AO2015DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015-16 DHS 5405 5837      
18 436573 SP/Fansidar 3+ doses, at least one during ANC visit 19 1 AO Angola 2015 AO2015DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015-16 DHS 5405 5837      
19 636245 SP/Fansidar use during pregnancy 0.1 1 BF Burkina Faso 2003 BF2003DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2003 DHS 4201 4121      
20 636246 SP/Fansidar 2+ doses during pregnancy 0 1 BF Burkina Faso 2003 BF2003DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2003 DHS 4201 4121      
21 636247 SP/Fansidar 3+ doses during pregnancy 0 1 BF Burkina Faso 2003 BF2003DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2003 DHS 4201 4121      
22 157531 SP/Fansidar use during pregnancy 73.8 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010 DHS 5988 5860      
23 157532 SP/Fansidar 2+ doses during pregnancy 38.5 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010 DHS 5988 5860      
24 157536 SP/Fansidar 3+ doses during pregnancy 5.2 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010 DHS 5988 5860      
25 157533 SP/Fansidar use during antenatal visit 71.1 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010 DHS 5988 5860      
26 157534 SP/Fansidar 2+ doses, at least one during ANC visit 38.2 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010 DHS 5988 5860      
27 157535 SP/Fansidar 3+ doses, at least one during ANC visit 5 1 BF Burkina Faso 2010 BF2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010 DHS 5988 5860      
28 282365 SP/Fansidar use during pregnancy 67.7 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014 MIS 2625 2673      
29 282366 SP/Fansidar 2+ doses during pregnancy 48.3 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014 MIS 2625 2673      
30 282363 SP/Fansidar 3+ doses during pregnancy 23.1 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014 MIS 2625 2673      
31 282367 SP/Fansidar use during antenatal visit 65.4 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014 MIS 2625 2673      
32 282368 SP/Fansidar 2+ doses, at least one during ANC visit 46.4 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014 MIS 2625 2673      
33 282389 SP/Fansidar 3+ doses, at least one during ANC visit 22.2 1 BF Burkina Faso 2014 BF2014MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014 MIS 2625 2673      
34 706681 SP/Fansidar use during pregnancy 93.7 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017-18 MIS 2402 2400      
35 706682 SP/Fansidar 2+ doses during pregnancy 82.3 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017-18 MIS 2402 2400      
36 706680 SP/Fansidar 3+ doses during pregnancy 57.7 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017-18 MIS 2402 2400      
37 706683 SP/Fansidar use during antenatal visit 92.9 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017-18 MIS 2402 2400      
38 706684 SP/Fansidar 2+ doses, at least one during ANC visit 81.6 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017-18 MIS 2402 2400      
39 706685 SP/Fansidar 3+ doses, at least one during ANC visit 57.2 1 BF Burkina Faso 2017 BF2017MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017-18 MIS 2402 2400      
40 562628 SP/Fansidar use during pregnancy 92.8 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 DHS 4684 4721      
41 562629 SP/Fansidar 2+ doses during pregnancy 79.1 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 DHS 4684 4721      
42 562627 SP/Fansidar 3+ doses during pregnancy 56.8 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 DHS 4684 4721      
43 562630 SP/Fansidar use during antenatal visit 91.6 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 DHS 4684 4721      
44 562631 SP/Fansidar 2+ doses, at least one during ANC visit 78.2 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 DHS 4684 4721      
45 562634 SP/Fansidar 3+ doses, at least one during ANC visit 56.3 1 BF Burkina Faso 2021 BF2021DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 DHS 4684 4721      
46 729781 SP/Fansidar use during pregnancy 4.9 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006 DHS 6380 6432      
47 729782 SP/Fansidar 2+ doses during pregnancy 3 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006 DHS 6380 6432      
48 729785 SP/Fansidar 3+ doses during pregnancy 1.2 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006 DHS 6380 6432      
49 729783 SP/Fansidar use during antenatal visit 0.2 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006 DHS 6380 6432      
50 729784 SP/Fansidar 2+ doses, at least one during ANC visit 0.1 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006 DHS 6380 6432      
51 729786 SP/Fansidar 3+ doses, at least one during ANC visit 0 1 BJ Benin 2006 BJ2006DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006 DHS 6380 6432      
52 623028 SP/Fansidar use during pregnancy 42.3 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011-12 DHS 5130 5178      
53 623029 SP/Fansidar 2+ doses during pregnancy 25.2 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011-12 DHS 5130 5178      
54 623026 SP/Fansidar 3+ doses during pregnancy 10 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011-12 DHS 5130 5178      
55 623030 SP/Fansidar use during antenatal visit 37.3 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011-12 DHS 5130 5178      
56 623031 SP/Fansidar 2+ doses, at least one during ANC visit 22.8 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011-12 DHS 5130 5178      
57 623025 SP/Fansidar 3+ doses, at least one during ANC visit 8.8 1 BJ Benin 2012 BJ2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011-12 DHS 5130 5178      
58 669873 SP/Fansidar use during pregnancy 50.3 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017-18 DHS 5502 5486      
59 669874 SP/Fansidar 2+ doses during pregnancy 34.2 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017-18 DHS 5502 5486      
60 669878 SP/Fansidar 3+ doses during pregnancy 13.7 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017-18 DHS 5502 5486      
61 669875 SP/Fansidar use during antenatal visit 49.1 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017-18 DHS 5502 5486      
62 669876 SP/Fansidar 2+ doses, at least one during ANC visit 33.4 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017-18 DHS 5502 5486      
63 669877 SP/Fansidar 3+ doses, at least one during ANC visit 13.3 1 BJ Benin 2017 BJ2017DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017-18 DHS 5502 5486      
64 282780 SP/Fansidar use during pregnancy 0.3 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010 DHS 3111 3030      
65 282781 SP/Fansidar 2+ doses during pregnancy 0.3 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010 DHS 3111 3030      
66 282779 SP/Fansidar 3+ doses during pregnancy 0.3 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010 DHS 3111 3030      
67 282782 SP/Fansidar use during antenatal visit 0.1 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010 DHS 3111 3030      
68 282783 SP/Fansidar 2+ doses, at least one during ANC visit 0.1 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010 DHS 3111 3030      
69 282784 SP/Fansidar 3+ doses, at least one during ANC visit 0.1 1 BU Burundi 2010 BU2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010 DHS 3111 3030      
70 649104 SP/Fansidar use during pregnancy 0.1 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 MIS 1786 1697      
71 649105 SP/Fansidar 2+ doses during pregnancy 0.1 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 MIS 1786 1697      
72 649106 SP/Fansidar 3+ doses during pregnancy 0 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 MIS 1786 1697      
73 649107 SP/Fansidar use during antenatal visit 0.1 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 MIS 1786 1697      
74 649108 SP/Fansidar 2+ doses, at least one during ANC visit 0.1 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 MIS 1786 1697      
75 649109 SP/Fansidar 3+ doses, at least one during ANC visit 0 1 BU Burundi 2012 BU2012MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 MIS 1786 1697      
76 282940 SP/Fansidar use during pregnancy 29.6 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016-17 DHS 5412 5261      
77 282947 SP/Fansidar 2+ doses during pregnancy 20.7 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016-17 DHS 5412 5261      
78 282939 SP/Fansidar 3+ doses during pregnancy 12.9 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016-17 DHS 5412 5261      
79 282948 SP/Fansidar use during antenatal visit 29.1 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016-17 DHS 5412 5261      
80 282950 SP/Fansidar 2+ doses, at least one during ANC visit 20.4 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016-17 DHS 5412 5261      
81 282952 SP/Fansidar 3+ doses, at least one during ANC visit 12.6 1 BU Burundi 2016 BU2016DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016-17 DHS 5412 5261      
82 491798 SP/Fansidar use during pregnancy 16.2 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2007 DHS 3435 3515      
83 491799 SP/Fansidar 2+ doses during pregnancy 6.9 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2007 DHS 3435 3515      
84 491808 SP/Fansidar 3+ doses during pregnancy 2.5 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2007 DHS 3435 3515      
85 491800 SP/Fansidar use during antenatal visit 12.1 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2007 DHS 3435 3515      
86 491806 SP/Fansidar 2+ doses, at least one during ANC visit 5.1 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2007 DHS 3435 3515      
87 491807 SP/Fansidar 3+ doses, at least one during ANC visit 1.9 1 CD Congo Democratic Republic 2007 CD2007DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2007 DHS 3435 3515      
88 638615 SP/Fansidar use during pregnancy 34.8 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013-14 DHS 7168 7322      
89 638616 SP/Fansidar 2+ doses during pregnancy 15 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013-14 DHS 7168 7322      
90 638620 SP/Fansidar 3+ doses during pregnancy 5.7 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013-14 DHS 7168 7322      
91 638617 SP/Fansidar use during antenatal visit 33 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013-14 DHS 7168 7322      
92 638618 SP/Fansidar 2+ doses, at least one during ANC visit 14.3 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013-14 DHS 7168 7322      
93 638619 SP/Fansidar 3+ doses, at least one during ANC visit 5.4 1 CD Congo Democratic Republic 2013 CD2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013-14 DHS 7168 7322      
94 466064 SP/Fansidar use during pregnancy 2 1 CG Congo 2005 CG2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005 DHS 2017 1980      
95 283182 SP/Fansidar use during pregnancy 46.8 1 CG Congo 2011 CG2011DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011-12 DHS 3426 3835      
96 283183 SP/Fansidar 2+ doses during pregnancy 24.9 1 CG Congo 2011 CG2011DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011-12 DHS 3426 3835      
97 283188 SP/Fansidar 3+ doses during pregnancy 12.1 1 CG Congo 2011 CG2011DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011-12 DHS 3426 3835      
98 283184 SP/Fansidar use during antenatal visit 42.1 1 CG Congo 2011 CG2011DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011-12 DHS 3426 3835      
99 283186 SP/Fansidar 2+ doses, at least one during ANC visit 22.2 1 CG Congo 2011 CG2011DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011-12 DHS 3426 3835      
100 283187 SP/Fansidar 3+ doses, at least one during ANC visit 10.5 1 CG Congo 2011 CG2011DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011-12 DHS 3426 3835      
101 700256 SP/Fansidar use during pregnancy 29 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011-12 DHS 3039 3113      
102 700257 SP/Fansidar 2+ doses during pregnancy 20 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011-12 DHS 3039 3113      
103 700261 SP/Fansidar 3+ doses during pregnancy 8.1 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011-12 DHS 3039 3113      
104 700258 SP/Fansidar use during antenatal visit 25.9 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011-12 DHS 3039 3113      
105 700259 SP/Fansidar 2+ doses, at least one during ANC visit 17.6 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011-12 DHS 3039 3113      
106 700260 SP/Fansidar 3+ doses, at least one during ANC visit 6.6 1 CI Cote d'Ivoire 2012 CI2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011-12 DHS 3039 3113      
107 730304 SP/Fansidar use during pregnancy 79.8 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 DHS 3858 4184      
108 730305 SP/Fansidar 2+ doses during pregnancy 58.3 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 DHS 3858 4184      
109 730318 SP/Fansidar 3+ doses during pregnancy 34.6 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 DHS 3858 4184      
110 730306 SP/Fansidar use during antenatal visit 77 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 DHS 3858 4184      
111 730316 SP/Fansidar 2+ doses, at least one during ANC visit 56.1 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 DHS 3858 4184      
112 730317 SP/Fansidar 3+ doses, at least one during ANC visit 33.1 1 CI Cote d'Ivoire 2021 CI2021DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 DHS 3858 4184      
113 132753 SP/Fansidar use during pregnancy 0.7 1 CM Cameroon 2004 CM2004DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2004 DHS 3173 3184      
114 647490 SP/Fansidar use during pregnancy 44 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 DHS 4705 4702      
115 647491 SP/Fansidar 2+ doses during pregnancy 26.7 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 DHS 4705 4702      
116 647489 SP/Fansidar 3+ doses during pregnancy 12 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 DHS 4705 4702      
117 647486 SP/Fansidar use during antenatal visit 41.9 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 DHS 4705 4702      
118 647487 SP/Fansidar 2+ doses, at least one during ANC visit 25.6 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 DHS 4705 4702      
119 647488 SP/Fansidar 3+ doses, at least one during ANC visit 11.5 1 CM Cameroon 2011 CM2011DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 DHS 4705 4702      
120 539222 SP/Fansidar use during pregnancy 74.5 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 3924 3788      
121 539223 SP/Fansidar 2+ doses during pregnancy 53.8 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 3924 3788      
122 539221 SP/Fansidar 3+ doses during pregnancy 31.9 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 3924 3788      
123 539224 SP/Fansidar use during antenatal visit 72.3 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 3924 3788      
124 539226 SP/Fansidar 2+ doses, at least one during ANC visit 52.2 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 3924 3788      
125 539227 SP/Fansidar 3+ doses, at least one during ANC visit 31.2 1 CM Cameroon 2018 CM2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 3924 3788      
126 161802 SP/Fansidar use during pregnancy 82.5 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2022 MIS 1746 1740      
127 161804 SP/Fansidar 2+ doses during pregnancy 67.1 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2022 MIS 1746 1740      
128 161803 SP/Fansidar 3+ doses during pregnancy 45.8 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2022 MIS 1746 1740      
129 161805 SP/Fansidar use during antenatal visit 81 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2022 MIS 1746 1740      
130 161806 SP/Fansidar 2+ doses, at least one during ANC visit 65.8 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2022 MIS 1746 1740      
131 161807 SP/Fansidar 3+ doses, at least one during ANC visit 45.2 1 CM Cameroon 2022 CM2022MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2022 MIS 1746 1740      
132 79362 SP/Fansidar use during pregnancy 2.1 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005 DHS 4321 3779      
133 79363 SP/Fansidar 2+ doses during pregnancy 1.2 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2005 DHS 4321 3779      
134 79361 SP/Fansidar 3+ doses during pregnancy 0.7 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2005 DHS 4321 3779      
135 79364 SP/Fansidar use during antenatal visit 0.5 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2005 DHS 4321 3779      
136 79365 SP/Fansidar 2+ doses, at least one during ANC visit 0.3 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2005 DHS 4321 3779      
137 79366 SP/Fansidar 3+ doses, at least one during ANC visit 0.2 1 ET Ethiopia 2005 ET2005DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2005 DHS 4321 3779      
138 644452 SP/Fansidar use during pregnancy 19.5 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 DHS 2102 2511      
139 644453 SP/Fansidar 2+ doses during pregnancy 13.1 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 DHS 2102 2511      
140 644457 SP/Fansidar 3+ doses during pregnancy 6.8 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 DHS 2102 2511      
141 644454 SP/Fansidar use during antenatal visit 18.6 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 DHS 2102 2511      
142 644455 SP/Fansidar 2+ doses, at least one during ANC visit 12.4 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 DHS 2102 2511      
143 644456 SP/Fansidar 3+ doses, at least one during ANC visit 6.3 1 GA Gabon 2012 GA2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 DHS 2102 2511      
144 445601 SP/Fansidar use during pregnancy 87.6 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019-21 DHS 2456 2519      
145 445602 SP/Fansidar 2+ doses during pregnancy 61.4 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019-21 DHS 2456 2519      
146 445600 SP/Fansidar 3+ doses during pregnancy 37.9 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019-21 DHS 2456 2519      
147 445603 SP/Fansidar use during antenatal visit 69 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019-21 DHS 2456 2519      
148 445618 SP/Fansidar 2+ doses, at least one during ANC visit 50.7 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019-21 DHS 2456 2519      
149 445619 SP/Fansidar 3+ doses, at least one during ANC visit 30.9 1 GA Gabon 2019 GA2019DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019-21 DHS 2456 2519      
150 284235 SP/Fansidar use during pregnancy 1.1 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2003 DHS 1421 1519      
151 284236 SP/Fansidar 2+ doses during pregnancy 1 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2003 DHS 1421 1519      
152 284250 SP/Fansidar 3+ doses during pregnancy 0.8 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2003 DHS 1421 1519      
153 284237 SP/Fansidar use during antenatal visit 0.8 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2003 DHS 1421 1519      
154 284238 SP/Fansidar 2+ doses, at least one during ANC visit 0.8 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2003 DHS 1421 1519      
155 284249 SP/Fansidar 3+ doses, at least one during ANC visit 0.6 1 GH Ghana 2003 GH2003DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2003 DHS 1421 1519      
156 211169 SP/Fansidar use during pregnancy 58.2 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008 DHS 1178 1225      
157 211170 SP/Fansidar 2+ doses during pregnancy 45.5 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008 DHS 1178 1225      
158 211168 SP/Fansidar 3+ doses during pregnancy 28 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008 DHS 1178 1225      
159 211171 SP/Fansidar use during antenatal visit 56 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008 DHS 1178 1225      
160 211173 SP/Fansidar 2+ doses, at least one during ANC visit 43.7 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008 DHS 1178 1225      
161 211174 SP/Fansidar 3+ doses, at least one during ANC visit 26.8 1 GH Ghana 2008 GH2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008 DHS 1178 1225      
162 27735 SP/Fansidar use during pregnancy 82.9 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014 DHS 2264 2329      
163 27740 SP/Fansidar 2+ doses during pregnancy 67.7 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014 DHS 2264 2329      
164 27744 SP/Fansidar 3+ doses during pregnancy 38.6 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014 DHS 2264 2329      
165 27741 SP/Fansidar use during antenatal visit 82.5 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014 DHS 2264 2329      
166 27742 SP/Fansidar 2+ doses, at least one during ANC visit 67.5 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014 DHS 2264 2329      
167 27743 SP/Fansidar 3+ doses, at least one during ANC visit 38.5 1 GH Ghana 2014 GH2014DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014 DHS 2264 2329      
168 44635 SP/Fansidar use during pregnancy 85.3 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 MIS 1285 1291      
169 44636 SP/Fansidar 2+ doses during pregnancy 78 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 MIS 1285 1291      
170 44640 SP/Fansidar 3+ doses during pregnancy 59.6 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 MIS 1285 1291      
171 44637 SP/Fansidar use during antenatal visit 85.3 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 MIS 1285 1291      
172 44638 SP/Fansidar 2+ doses, at least one during ANC visit 78 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 MIS 1285 1291      
173 44639 SP/Fansidar 3+ doses, at least one during ANC visit 59.6 1 GH Ghana 2016 GH2016MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 MIS 1285 1291      
174 452709 SP/Fansidar use during pregnancy 91.4 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019 MIS 1151 1215      
175 452710 SP/Fansidar 2+ doses during pregnancy 80.2 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019 MIS 1151 1215      
176 452712 SP/Fansidar 3+ doses during pregnancy 61 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019 MIS 1151 1215      
177 452711 SP/Fansidar use during antenatal visit 91.1 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019 MIS 1151 1215      
178 452713 SP/Fansidar 2+ doses, at least one during ANC visit 79.9 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019 MIS 1151 1215      
179 452714 SP/Fansidar 3+ doses, at least one during ANC visit 60.9 1 GH Ghana 2019 GH2019MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019 MIS 1151 1215      
180 718823 SP/Fansidar use during pregnancy 90 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2022 DHS 3491 3850      
181 718824 SP/Fansidar 2+ doses during pregnancy 77.5 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2022 DHS 3491 3850      
182 718822 SP/Fansidar 3+ doses during pregnancy 60.2 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2022 DHS 3491 3850      
183 718825 SP/Fansidar use during antenatal visit 89.1 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2022 DHS 3491 3850      
184 718844 SP/Fansidar 2+ doses, at least one during ANC visit 76.9 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2022 DHS 3491 3850      
185 718845 SP/Fansidar 3+ doses, at least one during ANC visit 59.8 1 GH Ghana 2022 GH2022DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2022 DHS 3491 3850      
186 284531 SP/Fansidar use during pregnancy 93.5 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 DHS 3392 3481      
187 284532 SP/Fansidar 2+ doses during pregnancy 63 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 DHS 3392 3481      
188 284526 SP/Fansidar 3+ doses during pregnancy 5.7 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 DHS 3392 3481      
189 284544 SP/Fansidar use during antenatal visit 92.3 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 DHS 3392 3481      
190 284545 SP/Fansidar 2+ doses, at least one during ANC visit 62.3 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 DHS 3392 3481      
191 284546 SP/Fansidar 3+ doses, at least one during ANC visit 5.7 1 GM Gambia 2013 GM2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 DHS 3392 3481      
192 638888 SP/Fansidar use during pregnancy 97.7 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019-20 DHS 3129 3441      
193 638889 SP/Fansidar 2+ doses during pregnancy 79.7 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019-20 DHS 3129 3441      
194 638893 SP/Fansidar 3+ doses during pregnancy 52.2 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019-20 DHS 3129 3441      
195 638890 SP/Fansidar use during antenatal visit 97.5 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019-20 DHS 3129 3441      
196 638891 SP/Fansidar 2+ doses, at least one during ANC visit 79.7 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019-20 DHS 3129 3441      
197 638894 SP/Fansidar 3+ doses, at least one during ANC visit 52.2 1 GM Gambia 2019 GM2019DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019-20 DHS 3129 3441      
198 710849 SP/Fansidar use during pregnancy 4.1 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005 DHS 2614 2586      
199 710850 SP/Fansidar 2+ doses during pregnancy 3.6 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2005 DHS 2614 2586      
200 710854 SP/Fansidar 3+ doses during pregnancy 2.8 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2005 DHS 2614 2586      
201 710851 SP/Fansidar use during antenatal visit 3.7 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2005 DHS 2614 2586      
202 710852 SP/Fansidar 2+ doses, at least one during ANC visit 3.2 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2005 DHS 2614 2586      
203 710853 SP/Fansidar 3+ doses, at least one during ANC visit 2.4 1 GN Guinea 2005 GN2005DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2005 DHS 2614 2586      
204 773701 SP/Fansidar use during pregnancy 31.7 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 DHS 2818 2810      
205 773702 SP/Fansidar 2+ doses during pregnancy 22.5 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 DHS 2818 2810      
206 773700 SP/Fansidar 3+ doses during pregnancy 11.2 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 DHS 2818 2810      
207 773703 SP/Fansidar use during antenatal visit 30.8 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 DHS 2818 2810      
208 773704 SP/Fansidar 2+ doses, at least one during ANC visit 22 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 DHS 2818 2810      
209 773705 SP/Fansidar 3+ doses, at least one during ANC visit 10.9 1 GN Guinea 2012 GN2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 DHS 2818 2810      
210 20935 SP/Fansidar use during pregnancy 80 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 3026 3066      
211 20936 SP/Fansidar 2+ doses during pregnancy 62.7 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 3026 3066      
212 20941 SP/Fansidar 3+ doses during pregnancy 35.7 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 3026 3066      
213 20938 SP/Fansidar use during antenatal visit 79.6 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 3026 3066      
214 20939 SP/Fansidar 2+ doses, at least one during ANC visit 62.4 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 3026 3066      
215 20940 SP/Fansidar 3+ doses, at least one during ANC visit 35.6 1 GN Guinea 2018 GN2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 3026 3066      
216 761713 SP/Fansidar use during pregnancy 89.3 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 MIS 1510 1511      
217 761714 SP/Fansidar 2+ doses during pregnancy 74.4 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 MIS 1510 1511      
218 761712 SP/Fansidar 3+ doses during pregnancy 50.3 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 MIS 1510 1511      
219 761715 SP/Fansidar use during antenatal visit 86.8 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 MIS 1510 1511      
220 761716 SP/Fansidar 2+ doses, at least one during ANC visit 72.5 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 MIS 1510 1511      
221 761717 SP/Fansidar 3+ doses, at least one during ANC visit 48.7 1 GN Guinea 2021 GN2021MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 MIS 1510 1511      
222 284680 SP/Fansidar use during pregnancy 0.2 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2009 DHS 750 869      
223 284681 SP/Fansidar 2+ doses during pregnancy 0.1 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2009 DHS 750 869      
224 284678 SP/Fansidar 3+ doses during pregnancy 0.1 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2009 DHS 750 869      
225 284682 SP/Fansidar use during antenatal visit 0.1 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2009 DHS 750 869      
226 284683 SP/Fansidar 2+ doses, at least one during ANC visit 0.1 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2009 DHS 750 869      
227 284684 SP/Fansidar 3+ doses, at least one during ANC visit 0.1 1 GY Guyana 2009 GY2009DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2009 DHS 750 869      
228 285147 SP/Fansidar use during pregnancy 14.5 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2003 DHS 2416 2357      
229 285148 SP/Fansidar 2+ doses during pregnancy 6.8 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2003 DHS 2416 2357      
230 285156 SP/Fansidar 3+ doses during pregnancy 3.1 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2003 DHS 2416 2357      
231 285149 SP/Fansidar use during antenatal visit 9.9 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2003 DHS 2416 2357      
232 285150 SP/Fansidar 2+ doses, at least one during ANC visit 4.5 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2003 DHS 2416 2357      
233 285154 SP/Fansidar 3+ doses, at least one during ANC visit 1.9 1 KE Kenya 2003 KE2003DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2003 DHS 2416 2357      
234 143584 SP/Fansidar use during pregnancy 35.5 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008-09 DHS 2264 2373      
235 143585 SP/Fansidar 2+ doses during pregnancy 15.1 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008-09 DHS 2264 2373      
236 143603 SP/Fansidar 3+ doses during pregnancy 6.9 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008-09 DHS 2264 2373      
237 143600 SP/Fansidar use during antenatal visit 33.6 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008-09 DHS 2264 2373      
238 143601 SP/Fansidar 2+ doses, at least one during ANC visit 14 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008-09 DHS 2264 2373      
239 143602 SP/Fansidar 3+ doses, at least one during ANC visit 6.2 1 KE Kenya 2008 KE2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008-09 DHS 2264 2373      
240 133413 SP/Fansidar use during pregnancy 30.4 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014 DHS 7357 7925      
241 133414 SP/Fansidar 2+ doses during pregnancy 17.2 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014 DHS 7357 7925      
242 133412 SP/Fansidar 3+ doses during pregnancy 10.3 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014 DHS 7357 7925      
243 133415 SP/Fansidar use during antenatal visit 29.6 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014 DHS 7357 7925      
244 133416 SP/Fansidar 2+ doses, at least one during ANC visit 16.9 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014 DHS 7357 7925      
245 133417 SP/Fansidar 3+ doses, at least one during ANC visit 10.1 1 KE Kenya 2014 KE2014DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014 DHS 7357 7925      
246 764719 SP/Fansidar use during pregnancy 52.6 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015 MIS 1268 1385      
247 764721 SP/Fansidar 2+ doses during pregnancy 35.9 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015 MIS 1268 1385      
248 764720 SP/Fansidar 3+ doses during pregnancy 22.9 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015 MIS 1268 1385      
249 764722 SP/Fansidar use during antenatal visit 50.8 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015 MIS 1268 1385      
250 764723 SP/Fansidar 2+ doses, at least one during ANC visit 34.7 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015 MIS 1268 1385      
251 764724 SP/Fansidar 3+ doses, at least one during ANC visit 21.9 1 KE Kenya 2015 KE2015MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015 MIS 1268 1385      
252 341687 SP/Fansidar use during pregnancy 37.8 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2020 MIS 1363 1481      
253 341688 SP/Fansidar 2+ doses during pregnancy 29.9 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2020 MIS 1363 1481      
254 341695 SP/Fansidar 3+ doses during pregnancy 22 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2020 MIS 1363 1481      
255 341689 SP/Fansidar use during antenatal visit 37 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2020 MIS 1363 1481      
256 341692 SP/Fansidar 2+ doses, at least one during ANC visit 29.5 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2020 MIS 1363 1481      
257 341693 SP/Fansidar 3+ doses, at least one during ANC visit 21.8 1 KE Kenya 2020 KE2020MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2020 MIS 1363 1481      
258 692882 SP/Fansidar use during pregnancy 28.2 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2022 DHS 3523 3985      
259 692883 SP/Fansidar 2+ doses during pregnancy 19.8 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2022 DHS 3523 3985      
260 692887 SP/Fansidar 3+ doses during pregnancy 12.5 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2022 DHS 3523 3985      
261 692884 SP/Fansidar use during antenatal visit 27.1 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2022 DHS 3523 3985      
262 692885 SP/Fansidar 2+ doses, at least one during ANC visit 19.3 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2022 DHS 3523 3985      
263 692886 SP/Fansidar 3+ doses, at least one during ANC visit 12.4 1 KE Kenya 2022 KE2022DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2022 DHS 3523 3985      
264 600276 SP/Fansidar use during pregnancy 50.8 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 DHS 1298 1255      
265 600280 SP/Fansidar 2+ doses during pregnancy 30.8 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 DHS 1298 1255      
266 600279 SP/Fansidar 3+ doses during pregnancy 11 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 DHS 1298 1255      
267 600281 SP/Fansidar use during antenatal visit 46.4 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 DHS 1298 1255      
268 600282 SP/Fansidar 2+ doses, at least one during ANC visit 27.8 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 DHS 1298 1255      
269 600283 SP/Fansidar 3+ doses, at least one during ANC visit 9.9 1 KM Comoros 2012 KM2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 DHS 1298 1255      
270 733487 SP/Fansidar use during pregnancy 57.9 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2009 MIS 1573 1644      
271 733488 SP/Fansidar 2+ doses during pregnancy 47.4 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2009 MIS 1573 1644      
272 733492 SP/Fansidar 3+ doses during pregnancy 11 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2009 MIS 1573 1644      
273 733489 SP/Fansidar use during antenatal visit 55.2 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2009 MIS 1573 1644      
274 733490 SP/Fansidar 2+ doses, at least one during ANC visit 45.1 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2009 MIS 1573 1644      
275 733491 SP/Fansidar 3+ doses, at least one during ANC visit 10.3 1 LB Liberia 2009 LB2009MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2009 MIS 1573 1644      
276 150729 SP/Fansidar use during pregnancy 63.2 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 MIS 1230 1326      
277 150730 SP/Fansidar 2+ doses during pregnancy 50.3 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 MIS 1230 1326      
278 150735 SP/Fansidar 3+ doses during pregnancy 26.5 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 MIS 1230 1326      
279 150731 SP/Fansidar use during antenatal visit 62 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 MIS 1230 1326      
280 150732 SP/Fansidar 2+ doses, at least one during ANC visit 49.6 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 MIS 1230 1326      
281 150733 SP/Fansidar 3+ doses, at least one during ANC visit 26.1 1 LB Liberia 2011 LB2011MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 MIS 1230 1326      
282 285839 SP/Fansidar use during pregnancy 68.1 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 DHS 2650 3064      
283 285840 SP/Fansidar 2+ doses during pregnancy 50.2 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 DHS 2650 3064      
284 285825 SP/Fansidar 3+ doses during pregnancy 17.9 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 DHS 2650 3064      
285 285841 SP/Fansidar use during antenatal visit 64.8 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 DHS 2650 3064      
286 285842 SP/Fansidar 2+ doses, at least one during ANC visit 47.6 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 DHS 2650 3064      
287 285843 SP/Fansidar 3+ doses, at least one during ANC visit 17.1 1 LB Liberia 2013 LB2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 DHS 2650 3064      
288 41416 SP/Fansidar use during pregnancy 84.8 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 MIS 1146 1219      
289 41411 SP/Fansidar 2+ doses during pregnancy 55.8 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 MIS 1146 1219      
290 41415 SP/Fansidar 3+ doses during pregnancy 23.1 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 MIS 1146 1219      
291 41412 SP/Fansidar use during antenatal visit 82.4 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 MIS 1146 1219      
292 41413 SP/Fansidar 2+ doses, at least one during ANC visit 54.5 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 MIS 1146 1219      
293 41414 SP/Fansidar 3+ doses, at least one during ANC visit 22.2 1 LB Liberia 2016 LB2016MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 MIS 1146 1219      
294 665171 SP/Fansidar use during pregnancy 90.3 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019-20 DHS 2096 2284      
295 665172 SP/Fansidar 2+ doses during pregnancy 70.1 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019-20 DHS 2096 2284      
296 665176 SP/Fansidar 3+ doses during pregnancy 40.3 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019-20 DHS 2096 2284      
297 665173 SP/Fansidar use during antenatal visit 88.9 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019-20 DHS 2096 2284      
298 665174 SP/Fansidar 2+ doses, at least one during ANC visit 69.2 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019-20 DHS 2096 2284      
299 665175 SP/Fansidar 3+ doses, at least one during ANC visit 40 1 LB Liberia 2019 LB2019DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019-20 DHS 2096 2284      
300 618418 SP/Fansidar use during pregnancy 93.4 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2022 MIS 1109 1171      
301 618419 SP/Fansidar 2+ doses during pregnancy 79.9 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2022 MIS 1109 1171      
302 618417 SP/Fansidar 3+ doses during pregnancy 62.6 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2022 MIS 1109 1171      
303 618420 SP/Fansidar use during antenatal visit 92.7 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2022 MIS 1109 1171      
304 618421 SP/Fansidar 2+ doses, at least one during ANC visit 79.5 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2022 MIS 1109 1171      
305 618422 SP/Fansidar 3+ doses, at least one during ANC visit 62.4 1 LB Liberia 2022 LB2022MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2022 MIS 1109 1171      
306 285893 SP/Fansidar use during pregnancy 11.8 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008-09 DHS 4807 4704      
307 285894 SP/Fansidar 2+ doses during pregnancy 6.7 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008-09 DHS 4807 4704      
308 285913 SP/Fansidar 3+ doses during pregnancy 1.9 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008-09 DHS 4807 4704      
309 285895 SP/Fansidar use during antenatal visit 11 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008-09 DHS 4807 4704      
310 285909 SP/Fansidar 2+ doses, at least one during ANC visit 6.4 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008-09 DHS 4807 4704      
311 285911 SP/Fansidar 3+ doses, at least one during ANC visit 1.8 1 MD Madagascar 2008 MD2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008-09 DHS 4807 4704      
312 452526 SP/Fansidar use during pregnancy 31.6 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 MIS 2477 2292      
313 452527 SP/Fansidar 2+ doses during pregnancy 19.5 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 MIS 2477 2292      
314 452525 SP/Fansidar 3+ doses during pregnancy 4.8 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 MIS 2477 2292      
315 452539 SP/Fansidar use during antenatal visit 30.6 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 MIS 2477 2292      
316 452540 SP/Fansidar 2+ doses, at least one during ANC visit 19.5 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 MIS 2477 2292      
317 452541 SP/Fansidar 3+ doses, at least one during ANC visit 4.8 1 MD Madagascar 2011 MD2011MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 MIS 2477 2292      
318 589152 SP/Fansidar use during pregnancy 30 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 MIS 2129 2160      
319 589153 SP/Fansidar 2+ doses during pregnancy 18.4 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 MIS 2129 2160      
320 589158 SP/Fansidar 3+ doses during pregnancy 3.9 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 MIS 2129 2160      
321 589154 SP/Fansidar use during antenatal visit 29.3 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 MIS 2129 2160      
322 589155 SP/Fansidar 2+ doses, at least one during ANC visit 18.2 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 MIS 2129 2160      
323 589157 SP/Fansidar 3+ doses, at least one during ANC visit 3.9 1 MD Madagascar 2013 MD2013MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 MIS 2129 2160      
324 465828 SP/Fansidar use during pregnancy 38.4 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 MIS 2786 2732      
325 465829 SP/Fansidar 2+ doses during pregnancy 23 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 MIS 2786 2732      
326 465833 SP/Fansidar 3+ doses during pregnancy 10.6 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 MIS 2786 2732      
327 465830 SP/Fansidar use during antenatal visit 37.4 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 MIS 2786 2732      
328 465831 SP/Fansidar 2+ doses, at least one during ANC visit 22.3 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 MIS 2786 2732      
329 465832 SP/Fansidar 3+ doses, at least one during ANC visit 10.3 1 MD Madagascar 2016 MD2016MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 MIS 2786 2732      
330 441733 SP/Fansidar use during pregnancy 50.9 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 DHS 4897 4946      
331 441749 SP/Fansidar 2+ doses during pregnancy 41.2 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 DHS 4897 4946      
332 441732 SP/Fansidar 3+ doses during pregnancy 31 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 DHS 4897 4946      
333 441750 SP/Fansidar use during antenatal visit 49.6 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 DHS 4897 4946      
334 441751 SP/Fansidar 2+ doses, at least one during ANC visit 40.2 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 DHS 4897 4946      
335 441752 SP/Fansidar 3+ doses, at least one during ANC visit 30.2 1 MD Madagascar 2021 MD2021DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 DHS 4897 4946      
336 82157 SP/Fansidar use during pregnancy 16.1 1 ML Mali 2006 ML2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006 DHS 5663 5581      
337 82158 SP/Fansidar 2+ doses during pregnancy 11.2 1 ML Mali 2006 ML2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006 DHS 5663 5581      
338 82162 SP/Fansidar 3+ doses during pregnancy 5.9 1 ML Mali 2006 ML2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006 DHS 5663 5581      
339 82159 SP/Fansidar use during antenatal visit 14.1 1 ML Mali 2006 ML2006DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006 DHS 5663 5581      
340 82160 SP/Fansidar 2+ doses, at least one during ANC visit 9.9 1 ML Mali 2006 ML2006DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006 DHS 5663 5581      
341 82161 SP/Fansidar 3+ doses, at least one during ANC visit 5 1 ML Mali 2006 ML2006DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006 DHS 5663 5581      
342 608230 SP/Fansidar use during pregnancy 56.2 1 ML Mali 2012 ML2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012-13 DHS 3965 3952      
343 608231 SP/Fansidar 2+ doses during pregnancy 30 1 ML Mali 2012 ML2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012-13 DHS 3965 3952      
344 608229 SP/Fansidar 3+ doses during pregnancy 11.8 1 ML Mali 2012 ML2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012-13 DHS 3965 3952      
345 608232 SP/Fansidar use during antenatal visit 48.8 1 ML Mali 2012 ML2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012-13 DHS 3965 3952      
346 608233 SP/Fansidar 2+ doses, at least one during ANC visit 28.5 1 ML Mali 2012 ML2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012-13 DHS 3965 3952      
347 608234 SP/Fansidar 3+ doses, at least one during ANC visit 11.1 1 ML Mali 2012 ML2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012-13 DHS 3965 3952      
348 515040 SP/Fansidar use during pregnancy 66.4 1 ML Mali 2015 ML2015MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015 MIS 3017 3007      
349 515041 SP/Fansidar 2+ doses during pregnancy 44.4 1 ML Mali 2015 ML2015MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015 MIS 3017 3007      
350 515046 SP/Fansidar 3+ doses during pregnancy 21 1 ML Mali 2015 ML2015MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015 MIS 3017 3007      
351 515042 SP/Fansidar use during antenatal visit 56 1 ML Mali 2015 ML2015MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015 MIS 3017 3007      
352 515044 SP/Fansidar 2+ doses, at least one during ANC visit 37.8 1 ML Mali 2015 ML2015MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015 MIS 3017 3007      
353 515045 SP/Fansidar 3+ doses, at least one during ANC visit 17.8 1 ML Mali 2015 ML2015MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015 MIS 3017 3007      
354 452312 SP/Fansidar use during pregnancy 74.2 1 ML Mali 2018 ML2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 4150 3926      
355 452313 SP/Fansidar 2+ doses during pregnancy 55.4 1 ML Mali 2018 ML2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 4150 3926      
356 452317 SP/Fansidar 3+ doses during pregnancy 28.3 1 ML Mali 2018 ML2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 4150 3926      
357 452314 SP/Fansidar use during antenatal visit 69 1 ML Mali 2018 ML2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 4150 3926      
358 452315 SP/Fansidar 2+ doses, at least one during ANC visit 51.4 1 ML Mali 2018 ML2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 4150 3926      
359 452316 SP/Fansidar 3+ doses, at least one during ANC visit 26.4 1 ML Mali 2018 ML2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 4150 3926      
360 335985 SP/Fansidar use during pregnancy 78.2 1 ML Mali 2021 ML2021MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 MIS 3665 3553      
361 335986 SP/Fansidar 2+ doses during pregnancy 56 1 ML Mali 2021 ML2021MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 MIS 3665 3553      
362 336011 SP/Fansidar 3+ doses during pregnancy 34.4 1 ML Mali 2021 ML2021MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 MIS 3665 3553      
363 335987 SP/Fansidar use during antenatal visit 75.4 1 ML Mali 2021 ML2021MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 MIS 3665 3553      
364 336009 SP/Fansidar 2+ doses, at least one during ANC visit 54.7 1 ML Mali 2021 ML2021MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 MIS 3665 3553      
365 336010 SP/Fansidar 3+ doses, at least one during ANC visit 33.8 1 ML Mali 2021 ML2021MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 MIS 3665 3553      
366 53786 SP/Fansidar use during pregnancy 54.5 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019-21 DHS 4485 4465      
367 53797 SP/Fansidar 2+ doses during pregnancy 23.2 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019-21 DHS 4485 4465      
368 53785 SP/Fansidar 3+ doses during pregnancy 10.2 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019-21 DHS 4485 4465      
369 53798 SP/Fansidar use during antenatal visit 53.2 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019-21 DHS 4485 4465      
370 53803 SP/Fansidar 2+ doses, at least one during ANC visit 22.9 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019-21 DHS 4485 4465      
371 53804 SP/Fansidar 3+ doses, at least one during ANC visit 10.1 1 MR Mauritania 2020 MR2020DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019-21 DHS 4485 4465      
372 692496 SP/Fansidar use during pregnancy 78.7 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2004 DHS 4604 4662      
373 692497 SP/Fansidar 2+ doses during pregnancy 46.5 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2004 DHS 4604 4662      
374 692490 SP/Fansidar 3+ doses during pregnancy 14.7 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2004 DHS 4604 4662      
375 692489 SP/Fansidar use during antenatal visit 72.9 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2004 DHS 4604 4662      
376 692491 SP/Fansidar 2+ doses, at least one during ANC visit 42.9 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2004 DHS 4604 4662      
377 692492 SP/Fansidar 3+ doses, at least one during ANC visit 13.7 1 MW Malawi 2004 MW2004DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2004 DHS 4604 4662      
378 204783 SP/Fansidar use during pregnancy 87.6 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010 DHS 7724 7755      
379 204784 SP/Fansidar 2+ doses during pregnancy 55 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010 DHS 7724 7755      
380 204786 SP/Fansidar 3+ doses during pregnancy 18.2 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010 DHS 7724 7755      
381 204785 SP/Fansidar use during antenatal visit 85.8 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010 DHS 7724 7755      
382 204787 SP/Fansidar 2+ doses, at least one during ANC visit 53.8 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010 DHS 7724 7755      
383 204788 SP/Fansidar 3+ doses, at least one during ANC visit 17.8 1 MW Malawi 2010 MW2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010 DHS 7724 7755      
384 287002 SP/Fansidar use during pregnancy 77.4 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 MIS 990 921      
385 287003 SP/Fansidar 2+ doses during pregnancy 53.8 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 MIS 990 921      
386 287016 SP/Fansidar 3+ doses during pregnancy 12.7 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 MIS 990 921      
387 287004 SP/Fansidar use during antenatal visit 76.2 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 MIS 990 921      
388 287005 SP/Fansidar 2+ doses, at least one during ANC visit 53.2 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 MIS 990 921      
389 287015 SP/Fansidar 3+ doses, at least one during ANC visit 12.7 1 MW Malawi 2012 MW2012MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 MIS 990 921      
390 287107 SP/Fansidar use during pregnancy 90.3 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014 MIS 946 884      
391 287108 SP/Fansidar 2+ doses during pregnancy 64.4 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014 MIS 946 884      
392 287106 SP/Fansidar 3+ doses during pregnancy 12.6 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014 MIS 946 884      
393 287109 SP/Fansidar use during antenatal visit 88.7 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014 MIS 946 884      
394 287110 SP/Fansidar 2+ doses, at least one during ANC visit 63.3 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014 MIS 946 884      
395 287113 SP/Fansidar 3+ doses, at least one during ANC visit 11.9 1 MW Malawi 2014 MW2014MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014 MIS 946 884      
396 129611 SP/Fansidar use during pregnancy 90.5 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015-16 DHS 6693 6683      
397 129612 SP/Fansidar 2+ doses during pregnancy 64.1 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015-16 DHS 6693 6683      
398 129616 SP/Fansidar 3+ doses during pregnancy 30.4 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015-16 DHS 6693 6683      
399 129613 SP/Fansidar use during antenatal visit 89.3 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015-16 DHS 6693 6683      
400 129614 SP/Fansidar 2+ doses, at least one during ANC visit 63.4 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015-16 DHS 6693 6683      
401 129615 SP/Fansidar 3+ doses, at least one during ANC visit 30 1 MW Malawi 2015 MW2015DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015-16 DHS 6693 6683      
402 118472 SP/Fansidar use during pregnancy 91.8 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017 MIS 1032 938      
403 118473 SP/Fansidar 2+ doses during pregnancy 76.1 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017 MIS 1032 938      
404 118477 SP/Fansidar 3+ doses during pregnancy 41.1 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017 MIS 1032 938      
405 118474 SP/Fansidar use during antenatal visit 91.5 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017 MIS 1032 938      
406 118475 SP/Fansidar 2+ doses, at least one during ANC visit 75.8 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017 MIS 1032 938      
407 118476 SP/Fansidar 3+ doses, at least one during ANC visit 40.9 1 MW Malawi 2017 MW2017MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017 MIS 1032 938      
408 578137 SP/Fansidar use during pregnancy 37.2 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 DHS 4913 4612      
409 578138 SP/Fansidar 2+ doses during pregnancy 19.6 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 DHS 4913 4612      
410 578142 SP/Fansidar 3+ doses during pregnancy 9.5 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 DHS 4913 4612      
411 578139 SP/Fansidar use during antenatal visit 34.9 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 DHS 4913 4612      
412 578140 SP/Fansidar 2+ doses, at least one during ANC visit 18.6 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 DHS 4913 4612      
413 578141 SP/Fansidar 3+ doses, at least one during ANC visit 9.2 1 MZ Mozambique 2011 MZ2011DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 DHS 4913 4612      
414 287603 SP/Fansidar use during pregnancy 54.4 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015 AIS 2257 2083      
415 287604 SP/Fansidar 2+ doses during pregnancy 35.8 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015 AIS 2257 2083      
416 287611 SP/Fansidar 3+ doses during pregnancy 23.3 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015 AIS 2257 2083      
417 287605 SP/Fansidar use during antenatal visit 51.4 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015 AIS 2257 2083      
418 287621 SP/Fansidar 2+ doses, at least one during ANC visit 34.2 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015 AIS 2257 2083      
419 287622 SP/Fansidar 3+ doses, at least one during ANC visit 22.4 1 MZ Mozambique 2015 MZ2015AIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015 AIS 2257 2083      
420 775977 SP/Fansidar use during pregnancy 84.2 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 MIS 2039 1898      
421 775978 SP/Fansidar 2+ doses during pregnancy 60.8 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 MIS 2039 1898      
422 775984 SP/Fansidar 3+ doses during pregnancy 40.6 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 MIS 2039 1898      
423 775979 SP/Fansidar use during antenatal visit 83.2 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 MIS 2039 1898      
424 775982 SP/Fansidar 2+ doses, at least one during ANC visit 60.4 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 MIS 2039 1898      
425 775983 SP/Fansidar 3+ doses, at least one during ANC visit 40.2 1 MZ Mozambique 2018 MZ2018MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 MIS 2039 1898      
426 287750 SP/Fansidar use during pregnancy 1.3 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2003 DHS 2447 2395      
427 287751 SP/Fansidar 2+ doses during pregnancy 1.1 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2003 DHS 2447 2395      
428 287752 SP/Fansidar 3+ doses during pregnancy 0.5 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2003 DHS 2447 2395      
429 287753 SP/Fansidar use during antenatal visit 0.8 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2003 DHS 2447 2395      
430 287754 SP/Fansidar 2+ doses, at least one during ANC visit 0.7 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2003 DHS 2447 2395      
431 287755 SP/Fansidar 3+ doses, at least one during ANC visit 0.4 1 NG Nigeria 2003 NG2003DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2003 DHS 2447 2395      
432 287805 SP/Fansidar use during pregnancy 10.9 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008 DHS 11027 11228      
433 287806 SP/Fansidar 2+ doses during pregnancy 6.5 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008 DHS 11027 11228      
434 287810 SP/Fansidar 3+ doses during pregnancy 3.2 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008 DHS 11027 11228      
435 287807 SP/Fansidar use during antenatal visit 8 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008 DHS 11027 11228      
436 287808 SP/Fansidar 2+ doses, at least one during ANC visit 4.9 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008 DHS 11027 11228      
437 287809 SP/Fansidar 3+ doses, at least one during ANC visit 2.4 1 NG Nigeria 2008 NG2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008 DHS 11027 11228      
438 287837 SP/Fansidar use during pregnancy 20.2 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010 MIS 2255 2170      
439 287838 SP/Fansidar 2+ doses during pregnancy 14.6 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010 MIS 2255 2170      
440 287854 SP/Fansidar 3+ doses during pregnancy 5.7 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010 MIS 2255 2170      
441 287839 SP/Fansidar use during antenatal visit 17.4 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010 MIS 2255 2170      
442 287840 SP/Fansidar 2+ doses, at least one during ANC visit 13.2 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010 MIS 2255 2170      
443 287841 SP/Fansidar 3+ doses, at least one during ANC visit 5.1 1 NG Nigeria 2010 NG2010MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010 MIS 2255 2170      
444 39292 SP/Fansidar use during pregnancy 27.3 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 DHS 12473 12397      
445 39293 SP/Fansidar 2+ doses during pregnancy 17.4 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 DHS 12473 12397      
446 39291 SP/Fansidar 3+ doses during pregnancy 7.1 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 DHS 12473 12397      
447 39294 SP/Fansidar use during antenatal visit 22.6 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 DHS 12473 12397      
448 39287 SP/Fansidar 2+ doses, at least one during ANC visit 14.6 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 DHS 12473 12397      
449 39288 SP/Fansidar 3+ doses, at least one during ANC visit 5.8 1 NG Nigeria 2013 NG2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 DHS 12473 12397      
450 763248 SP/Fansidar use during pregnancy 51.4 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015 MIS 2522 2490      
451 763249 SP/Fansidar 2+ doses during pregnancy 40.9 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015 MIS 2522 2490      
452 763253 SP/Fansidar 3+ doses during pregnancy 21.4 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015 MIS 2522 2490      
453 763250 SP/Fansidar use during antenatal visit 46.6 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015 MIS 2522 2490      
454 763251 SP/Fansidar 2+ doses, at least one during ANC visit 37.2 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015 MIS 2522 2490      
455 763252 SP/Fansidar 3+ doses, at least one during ANC visit 19 1 NG Nigeria 2015 NG2015MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015 MIS 2522 2490      
456 452363 SP/Fansidar use during pregnancy 63.6 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 12935 12818      
457 452364 SP/Fansidar 2+ doses during pregnancy 40.4 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 12935 12818      
458 452369 SP/Fansidar 3+ doses during pregnancy 16.6 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 12935 12818      
459 452365 SP/Fansidar use during antenatal visit 56.7 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 12935 12818      
460 452366 SP/Fansidar 2+ doses, at least one during ANC visit 36 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 12935 12818      
461 452368 SP/Fansidar 3+ doses, at least one during ANC visit 14.6 1 NG Nigeria 2018 NG2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 12935 12818      
462 153017 SP/Fansidar use during pregnancy 58.9 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 MIS 4087 3928      
463 153018 SP/Fansidar 2+ doses during pregnancy 45.9 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 MIS 4087 3928      
464 153016 SP/Fansidar 3+ doses during pregnancy 31 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 MIS 4087 3928      
465 153019 SP/Fansidar use during antenatal visit 56 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 MIS 4087 3928      
466 153020 SP/Fansidar 2+ doses, at least one during ANC visit 43.7 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 MIS 4087 3928      
467 153021 SP/Fansidar 3+ doses, at least one during ANC visit 29.5 1 NG Nigeria 2021 NG2021MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 MIS 4087 3928      
468 77364 SP/Fansidar use during pregnancy 0.5 1 NI Niger 2006 NI2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006 DHS 3918 3613      
469 77365 SP/Fansidar 2+ doses during pregnancy 0.5 1 NI Niger 2006 NI2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006 DHS 3918 3613      
470 77385 SP/Fansidar 3+ doses during pregnancy 0.4 1 NI Niger 2006 NI2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006 DHS 3918 3613      
471 77366 SP/Fansidar use during antenatal visit 0.4 1 NI Niger 2006 NI2006DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006 DHS 3918 3613      
472 77367 SP/Fansidar 2+ doses, at least one during ANC visit 0.4 1 NI Niger 2006 NI2006DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006 DHS 3918 3613      
473 77368 SP/Fansidar 3+ doses, at least one during ANC visit 0.3 1 NI Niger 2006 NI2006DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006 DHS 3918 3613      
474 185075 SP/Fansidar use during pregnancy 62.7 1 NI Niger 2012 NI2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012 DHS 5143 4759      
475 185076 SP/Fansidar 2+ doses during pregnancy 36.9 1 NI Niger 2012 NI2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012 DHS 5143 4759      
476 185081 SP/Fansidar 3+ doses during pregnancy 9.1 1 NI Niger 2012 NI2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012 DHS 5143 4759      
477 185077 SP/Fansidar use during antenatal visit 59.4 1 NI Niger 2012 NI2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012 DHS 5143 4759      
478 185078 SP/Fansidar 2+ doses, at least one during ANC visit 34.8 1 NI Niger 2012 NI2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012 DHS 5143 4759      
479 185079 SP/Fansidar 3+ doses, at least one during ANC visit 8.6 1 NI Niger 2012 NI2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012 DHS 5143 4759      
480 287672 SP/Fansidar use during pregnancy 81.6 1 NI Niger 2021 NI2021MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2021 MIS 2066 1989      
481 287673 SP/Fansidar 2+ doses during pregnancy 56.2 1 NI Niger 2021 NI2021MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2021 MIS 2066 1989      
482 287670 SP/Fansidar 3+ doses during pregnancy 25 1 NI Niger 2021 NI2021MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2021 MIS 2066 1989      
483 287674 SP/Fansidar use during antenatal visit 80.7 1 NI Niger 2021 NI2021MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2021 MIS 2066 1989      
484 287675 SP/Fansidar 2+ doses, at least one during ANC visit 55.8 1 NI Niger 2021 NI2021MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2021 MIS 2066 1989      
485 287676 SP/Fansidar 3+ doses, at least one during ANC visit 24.9 1 NI Niger 2021 NI2021MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2021 MIS 2066 1989      
486 113296 SP/Fansidar use during pregnancy 27.8 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006-07 DHS 2054 2135      
487 113297 SP/Fansidar 2+ doses during pregnancy 10.6 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006-07 DHS 2054 2135      
488 113306 SP/Fansidar 3+ doses during pregnancy 7 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006-07 DHS 2054 2135      
489 113298 SP/Fansidar use during antenatal visit 19.6 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006-07 DHS 2054 2135      
490 113299 SP/Fansidar 2+ doses, at least one during ANC visit 10 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006-07 DHS 2054 2135      
491 113304 SP/Fansidar 3+ doses, at least one during ANC visit 6.7 1 NM Namibia 2006 NM2006DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006-07 DHS 2054 2135      
492 772436 SP/Fansidar use during pregnancy 9.1 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 DHS 1947 2051      
493 772437 SP/Fansidar 2+ doses during pregnancy 5.1 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 DHS 1947 2051      
494 772444 SP/Fansidar 3+ doses during pregnancy 3.4 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 DHS 1947 2051      
495 772438 SP/Fansidar use during antenatal visit 7.5 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 DHS 1947 2051      
496 772439 SP/Fansidar 2+ doses, at least one during ANC visit 4.9 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 DHS 1947 2051      
497 772443 SP/Fansidar 3+ doses, at least one during ANC visit 3.3 1 NM Namibia 2013 NM2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 DHS 1947 2051      
498 19961 SP/Fansidar use during pregnancy 50.2 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016-18 DHS 3642 3605      
499 19962 SP/Fansidar 2+ doses during pregnancy 35.7 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016-18 DHS 3642 3605      
500 19966 SP/Fansidar 3+ doses during pregnancy 23.5 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016-18 DHS 3642 3605      
501 19963 SP/Fansidar use during antenatal visit 48.1 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016-18 DHS 3642 3605      
502 19964 SP/Fansidar 2+ doses, at least one during ANC visit 35 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016-18 DHS 3642 3605      
503 19965 SP/Fansidar 3+ doses, at least one during ANC visit 23 1 PG Papua New Guinea 2017 PG2017DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016-18 DHS 3642 3605      
504 719205 SP/Fansidar use during pregnancy 1.6 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005 DHS 3436 3412      
505 719206 SP/Fansidar 2+ doses during pregnancy 0.9 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2005 DHS 3436 3412      
506 719211 SP/Fansidar 3+ doses during pregnancy 0.5 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2005 DHS 3436 3412      
507 719207 SP/Fansidar use during antenatal visit 0.4 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2005 DHS 3436 3412      
508 719208 SP/Fansidar 2+ doses, at least one during ANC visit 0.2 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2005 DHS 3436 3412      
509 719209 SP/Fansidar 3+ doses, at least one during ANC visit 0.1 1 RW Rwanda 2005 RW2005DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2005 DHS 3436 3412      
510 676559 SP/Fansidar use during pregnancy 53 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2007-08 DHS 2267 2184      
511 676560 SP/Fansidar 2+ doses during pregnancy 17.7 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2007-08 DHS 2267 2184      
512 676577 SP/Fansidar 3+ doses during pregnancy 3.7 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2007-08 DHS 2267 2184      
513 676561 SP/Fansidar use during antenatal visit 51.3 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2007-08 DHS 2267 2184      
514 676575 SP/Fansidar 2+ doses, at least one during ANC visit 17.2 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2007-08 DHS 2267 2184      
515 676576 SP/Fansidar 3+ doses, at least one during ANC visit 3.5 1 RW Rwanda 2008 RW2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2007-08 DHS 2267 2184      
516 244130 SP/Fansidar use during pregnancy 19.5 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008 DHS 2478 2410      
517 244133 SP/Fansidar 2+ doses during pregnancy 12 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008 DHS 2478 2410      
518 244129 SP/Fansidar 3+ doses during pregnancy 5.2 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008 DHS 2478 2410      
519 244134 SP/Fansidar use during antenatal visit 16.8 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008 DHS 2478 2410      
520 244135 SP/Fansidar 2+ doses, at least one during ANC visit 10.3 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008 DHS 2478 2410      
521 244136 SP/Fansidar 3+ doses, at least one during ANC visit 4.7 1 SL Sierra Leone 2008 SL2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008 DHS 2478 2410      
522 631122 SP/Fansidar use during pregnancy 64.8 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013 DHS 4820 4668      
523 631123 SP/Fansidar 2+ doses during pregnancy 46.9 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013 DHS 4820 4668      
524 631129 SP/Fansidar 3+ doses during pregnancy 20.7 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013 DHS 4820 4668      
525 631125 SP/Fansidar use during antenatal visit 62.1 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013 DHS 4820 4668      
526 631127 SP/Fansidar 2+ doses, at least one during ANC visit 45.1 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013 DHS 4820 4668      
527 631128 SP/Fansidar 3+ doses, at least one during ANC visit 19.7 1 SL Sierra Leone 2013 SL2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013 DHS 4820 4668      
528 459029 SP/Fansidar use during pregnancy 90.6 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 MIS 2451 2554      
529 459030 SP/Fansidar 2+ doses during pregnancy 71.6 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 MIS 2451 2554      
530 459037 SP/Fansidar 3+ doses during pregnancy 31.1 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 MIS 2451 2554      
531 459031 SP/Fansidar use during antenatal visit 90.3 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 MIS 2451 2554      
532 459032 SP/Fansidar 2+ doses, at least one during ANC visit 71.3 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 MIS 2451 2554      
533 459036 SP/Fansidar 3+ doses, at least one during ANC visit 31 1 SL Sierra Leone 2016 SL2016MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 MIS 2451 2554      
534 742228 SP/Fansidar use during pregnancy 93.5 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019 DHS 3950 3970      
535 742229 SP/Fansidar 2+ doses during pregnancy 73.8 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019 DHS 3950 3970      
536 742233 SP/Fansidar 3+ doses during pregnancy 35.7 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019 DHS 3950 3970      
537 742230 SP/Fansidar use during antenatal visit 92.2 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019 DHS 3950 3970      
538 742231 SP/Fansidar 2+ doses, at least one during ANC visit 73 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019 DHS 3950 3970      
539 742232 SP/Fansidar 3+ doses, at least one during ANC visit 35.2 1 SL Sierra Leone 2019 SL2019DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019 DHS 3950 3970      
540 89594 SP/Fansidar use during pregnancy 23.5 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005 DHS 4391 4551      
541 89595 SP/Fansidar 2+ doses during pregnancy 13.2 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2005 DHS 4391 4551      
542 89597 SP/Fansidar 3+ doses during pregnancy 3.8 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2005 DHS 4391 4551      
543 89596 SP/Fansidar use during antenatal visit 20.6 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2005 DHS 4391 4551      
544 89598 SP/Fansidar 2+ doses, at least one during ANC visit 11.9 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2005 DHS 4391 4551      
545 89605 SP/Fansidar 3+ doses, at least one during ANC visit 3.4 1 SN Senegal 2005 SN2005DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2005 DHS 4391 4551      
546 138756 SP/Fansidar use during pregnancy 71.8 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006 MIS 1906 1963      
547 138757 SP/Fansidar 2+ doses during pregnancy 51.2 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006 MIS 1906 1963      
548 138761 SP/Fansidar 3+ doses during pregnancy 7 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006 MIS 1906 1963      
549 138758 SP/Fansidar use during antenatal visit 68.7 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006 MIS 1906 1963      
550 138759 SP/Fansidar 2+ doses, at least one during ANC visit 49.3 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006 MIS 1906 1963      
551 138760 SP/Fansidar 3+ doses, at least one during ANC visit 6.7 1 SN Senegal 2006 SN2006MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006 MIS 1906 1963      
552 484124 SP/Fansidar use during pregnancy 78.1 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008-09 MIS 5406 5883      
553 484126 SP/Fansidar 2+ doses during pregnancy 53.7 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008-09 MIS 5406 5883      
554 484125 SP/Fansidar 3+ doses during pregnancy 15.4 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008-09 MIS 5406 5883      
555 484137 SP/Fansidar use during antenatal visit 75.5 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008-09 MIS 5406 5883      
556 484138 SP/Fansidar 2+ doses, at least one during ANC visit 52.2 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008-09 MIS 5406 5883      
557 484139 SP/Fansidar 3+ doses, at least one during ANC visit 15 1 SN Senegal 2008 SN2008MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008-09 MIS 5406 5883      
558 200693 SP/Fansidar use during pregnancy 68.1 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010-11 DHS 4516 4913      
559 200694 SP/Fansidar 2+ doses during pregnancy 40 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010-11 DHS 4516 4913      
560 200698 SP/Fansidar 3+ doses during pregnancy 13.2 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010-11 DHS 4516 4913      
561 200695 SP/Fansidar use during antenatal visit 64.9 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010-11 DHS 4516 4913      
562 200696 SP/Fansidar 2+ doses, at least one during ANC visit 38.6 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010-11 DHS 4516 4913      
563 200697 SP/Fansidar 3+ doses, at least one during ANC visit 12.7 1 SN Senegal 2010 SN2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010-11 DHS 4516 4913      
564 102827 SP/Fansidar use during pregnancy 75.5 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2012-13 DHS 2509 2710      
565 102828 SP/Fansidar 2+ doses during pregnancy 42.2 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2012-13 DHS 2509 2710      
566 102831 SP/Fansidar 3+ doses during pregnancy 4.6 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2012-13 DHS 2509 2710      
567 102829 SP/Fansidar use during antenatal visit 73.5 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2012-13 DHS 2509 2710      
568 102830 SP/Fansidar 2+ doses, at least one during ANC visit 41.3 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2012-13 DHS 2509 2710      
569 102832 SP/Fansidar 3+ doses, at least one during ANC visit 4.5 1 SN Senegal 2012 SN2012DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2012-13 DHS 2509 2710      
570 138676 SP/Fansidar use during pregnancy 78.9 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014 DHS 2342 2584      
571 138677 SP/Fansidar 2+ doses during pregnancy 43.4 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014 DHS 2342 2584      
572 138680 SP/Fansidar 3+ doses during pregnancy 2.8 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014 DHS 2342 2584      
573 138678 SP/Fansidar use during antenatal visit 71.1 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014 DHS 2342 2584      
574 138679 SP/Fansidar 2+ doses, at least one during ANC visit 40 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014 DHS 2342 2584      
575 138681 SP/Fansidar 3+ doses, at least one during ANC visit 2.5 1 SN Senegal 2014 SN2014DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014 DHS 2342 2584      
576 114845 SP/Fansidar use during pregnancy 77.4 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015 DHS 2414 2712      
577 114846 SP/Fansidar 2+ doses during pregnancy 52.7 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015 DHS 2414 2712      
578 114850 SP/Fansidar 3+ doses during pregnancy 11.2 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015 DHS 2414 2712      
579 114847 SP/Fansidar use during antenatal visit 71.7 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015 DHS 2414 2712      
580 114848 SP/Fansidar 2+ doses, at least one during ANC visit 49.4 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015 DHS 2414 2712      
581 114849 SP/Fansidar 3+ doses, at least one during ANC visit 10.6 1 SN Senegal 2015 SN2015DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015 DHS 2414 2712      
582 245781 SP/Fansidar use during pregnancy 91.6 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 DHS 2316 2641      
583 245782 SP/Fansidar 2+ doses during pregnancy 62.5 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 DHS 2316 2641      
584 245777 SP/Fansidar 3+ doses during pregnancy 22.1 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 DHS 2316 2641      
585 245783 SP/Fansidar use during antenatal visit 87.5 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 DHS 2316 2641      
586 245784 SP/Fansidar 2+ doses, at least one during ANC visit 60.3 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 DHS 2316 2641      
587 245785 SP/Fansidar 3+ doses, at least one during ANC visit 21.5 1 SN Senegal 2016 SN2016DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 DHS 2316 2641      
588 638844 SP/Fansidar use during pregnancy 94.3 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017 DHS 4447 4818      
589 638845 SP/Fansidar 2+ doses during pregnancy 62.6 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017 DHS 4447 4818      
590 638843 SP/Fansidar 3+ doses during pregnancy 22 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017 DHS 4447 4818      
591 638846 SP/Fansidar use during antenatal visit 92.2 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017 DHS 4447 4818      
592 638847 SP/Fansidar 2+ doses, at least one during ANC visit 61.3 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017 DHS 4447 4818      
593 638848 SP/Fansidar 3+ doses, at least one during ANC visit 21.6 1 SN Senegal 2017 SN2017DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017 DHS 4447 4818      
594 528497 SP/Fansidar use during pregnancy 93.1 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 2435 2681      
595 528498 SP/Fansidar 2+ doses during pregnancy 64.4 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 2435 2681      
596 528506 SP/Fansidar 3+ doses during pregnancy 22.4 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 2435 2681      
597 528503 SP/Fansidar use during antenatal visit 90.8 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 2435 2681      
598 528504 SP/Fansidar 2+ doses, at least one during ANC visit 62.7 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 2435 2681      
599 528505 SP/Fansidar 3+ doses, at least one during ANC visit 21.6 1 SN Senegal 2018 SN2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 2435 2681      
600 3557 SP/Fansidar use during pregnancy 92.5 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2019 DHS 2327 2465      
601 3558 SP/Fansidar 2+ doses during pregnancy 62.9 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2019 DHS 2327 2465      
602 3556 SP/Fansidar 3+ doses during pregnancy 19.6 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2019 DHS 2327 2465      
603 3565 SP/Fansidar use during antenatal visit 88.4 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2019 DHS 2327 2465      
604 3566 SP/Fansidar 2+ doses, at least one during ANC visit 59.9 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2019 DHS 2327 2465      
605 3567 SP/Fansidar 3+ doses, at least one during ANC visit 18.7 1 SN Senegal 2019 SN2019DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2019 DHS 2327 2465      
606 337925 SP/Fansidar use during pregnancy 92.3 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2020-21 MIS 2356 2637      
607 337926 SP/Fansidar 2+ doses during pregnancy 67.4 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2020-21 MIS 2356 2637      
608 337935 SP/Fansidar 3+ doses during pregnancy 37.7 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2020-21 MIS 2356 2637      
609 337927 SP/Fansidar use during antenatal visit 86.1 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2020-21 MIS 2356 2637      
610 337928 SP/Fansidar 2+ doses, at least one during ANC visit 64.4 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2020-21 MIS 2356 2637      
611 337929 SP/Fansidar 3+ doses, at least one during ANC visit 36 1 SN Senegal 2020 SN2020MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2020-21 MIS 2356 2637      
612 51299 SP/Fansidar use during pregnancy 88.1 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2008-09 DHS 733 778      
613 51300 SP/Fansidar 2+ doses during pregnancy 61.6 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2008-09 DHS 733 778      
614 51304 SP/Fansidar 3+ doses during pregnancy 5 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2008-09 DHS 733 778      
615 51301 SP/Fansidar use during antenatal visit 85 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2008-09 DHS 733 778      
616 51302 SP/Fansidar 2+ doses, at least one during ANC visit 59.8 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2008-09 DHS 733 778      
617 51303 SP/Fansidar 3+ doses, at least one during ANC visit 4.9 1 ST Sao Tome and Principe 2008 ST2008DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2008-09 DHS 733 778      
618 710368 SP/Fansidar use during pregnancy 1.5 1 SZ Eswatini 2006 SZ2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006-07 DHS 1147 1152      
619 710369 SP/Fansidar 2+ doses during pregnancy 0.5 1 SZ Eswatini 2006 SZ2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006-07 DHS 1147 1152      
620 710370 SP/Fansidar 3+ doses during pregnancy 0.5 1 SZ Eswatini 2006 SZ2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006-07 DHS 1147 1152      
621 3886 SP/Fansidar use during pregnancy 0.3 1 TD Chad 2004 TD2004DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2004 DHS 2251 2116      
622 54437 SP/Fansidar use during pregnancy 24.2 1 TD Chad 2014 TD2014DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014-15 DHS 6742 6590      
623 54443 SP/Fansidar 2+ doses during pregnancy 18.1 1 TD Chad 2014 TD2014DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014-15 DHS 6742 6590      
624 54445 SP/Fansidar 3+ doses during pregnancy 8.5 1 TD Chad 2014 TD2014DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014-15 DHS 6742 6590      
625 54444 SP/Fansidar use during antenatal visit 21.7 1 TD Chad 2014 TD2014DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014-15 DHS 6742 6590      
626 54446 SP/Fansidar 2+ doses, at least one during ANC visit 16.4 1 TD Chad 2014 TD2014DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014-15 DHS 6742 6590      
627 54447 SP/Fansidar 3+ doses, at least one during ANC visit 7.6 1 TD Chad 2014 TD2014DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014-15 DHS 6742 6590      
628 663763 SP/Fansidar use during pregnancy 76.8 1 TG Togo 2013 TG2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013-14 DHS 2682 2782      
629 663764 SP/Fansidar 2+ doses during pregnancy 56.7 1 TG Togo 2013 TG2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013-14 DHS 2682 2782      
630 663752 SP/Fansidar 3+ doses during pregnancy 22.8 1 TG Togo 2013 TG2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013-14 DHS 2682 2782      
631 663765 SP/Fansidar use during antenatal visit 58.7 1 TG Togo 2013 TG2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013-14 DHS 2682 2782      
632 663766 SP/Fansidar 2+ doses, at least one during ANC visit 43.6 1 TG Togo 2013 TG2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013-14 DHS 2682 2782      
633 663767 SP/Fansidar 3+ doses, at least one during ANC visit 19 1 TG Togo 2013 TG2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013-14 DHS 2682 2782      
634 774155 SP/Fansidar use during pregnancy 87.9 1 TG Togo 2017 TG2017MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017 MIS 1315 1405      
635 774157 SP/Fansidar 2+ doses during pregnancy 68.2 1 TG Togo 2017 TG2017MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017 MIS 1315 1405      
636 774161 SP/Fansidar 3+ doses during pregnancy 41.7 1 TG Togo 2017 TG2017MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017 MIS 1315 1405      
637 774158 SP/Fansidar use during antenatal visit 86.8 1 TG Togo 2017 TG2017MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017 MIS 1315 1405      
638 774159 SP/Fansidar 2+ doses, at least one during ANC visit 67.6 1 TG Togo 2017 TG2017MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017 MIS 1315 1405      
639 774160 SP/Fansidar 3+ doses, at least one during ANC visit 41.2 1 TG Togo 2017 TG2017MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017 MIS 1315 1405      
640 175836 SP/Fansidar use during pregnancy 53.3 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2004-05 DHS 3500 3390      
641 175837 SP/Fansidar 2+ doses during pregnancy 22.3 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2004-05 DHS 3500 3390      
642 175835 SP/Fansidar 3+ doses during pregnancy 2.8 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2004-05 DHS 3500 3390      
643 175838 SP/Fansidar use during antenatal visit 49.5 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2004-05 DHS 3500 3390      
644 175839 SP/Fansidar 2+ doses, at least one during ANC visit 20.6 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2004-05 DHS 3500 3390      
645 175840 SP/Fansidar 3+ doses, at least one during ANC visit 2.7 1 TZ Tanzania 2004 TZ2004DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2004-05 DHS 3500 3390      
646 89648 SP/Fansidar use during pregnancy 58.9 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2007-08 AIS 3046 2968      
647 89649 SP/Fansidar 2+ doses during pregnancy 30.7 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2007-08 AIS 3046 2968      
648 89647 SP/Fansidar 3+ doses during pregnancy 7 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2007-08 AIS 3046 2968      
649 89650 SP/Fansidar use during antenatal visit 57.4 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2007-08 AIS 3046 2968      
650 89651 SP/Fansidar 2+ doses, at least one during ANC visit 30.1 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2007-08 AIS 3046 2968      
651 89652 SP/Fansidar 3+ doses, at least one during ANC visit 6.8 1 TZ Tanzania 2007 TZ2007AIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2007-08 AIS 3046 2968      
652 192719 SP/Fansidar use during pregnancy 63.3 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010 DHS 3266 3173      
653 192720 SP/Fansidar 2+ doses during pregnancy 27.2 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010 DHS 3266 3173      
654 192718 SP/Fansidar 3+ doses during pregnancy 2.7 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010 DHS 3266 3173      
655 192721 SP/Fansidar use during antenatal visit 60.5 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010 DHS 3266 3173      
656 192722 SP/Fansidar 2+ doses, at least one during ANC visit 26.3 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010 DHS 3266 3173      
657 192723 SP/Fansidar 3+ doses, at least one during ANC visit 2.6 1 TZ Tanzania 2010 TZ2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010 DHS 3266 3173      
658 248730 SP/Fansidar use during pregnancy 62.6 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011-12 AIS 3555 3525      
659 248731 SP/Fansidar 2+ doses during pregnancy 33.2 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011-12 AIS 3555 3525      
660 248743 SP/Fansidar 3+ doses during pregnancy 4 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011-12 AIS 3555 3525      
661 248732 SP/Fansidar use during antenatal visit 59.6 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011-12 AIS 3555 3525      
662 248733 SP/Fansidar 2+ doses, at least one during ANC visit 31.8 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011-12 AIS 3555 3525      
663 248741 SP/Fansidar 3+ doses, at least one during ANC visit 3.9 1 TZ Tanzania 2012 TZ2012AIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011-12 AIS 3555 3525      
664 249212 SP/Fansidar use during pregnancy 69.4 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2015-16 DHS 4167 4219      
665 249213 SP/Fansidar 2+ doses during pregnancy 35.3 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2015-16 DHS 4167 4219      
666 249210 SP/Fansidar 3+ doses during pregnancy 8 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2015-16 DHS 4167 4219      
667 249223 SP/Fansidar use during antenatal visit 68.3 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2015-16 DHS 4167 4219      
668 249224 SP/Fansidar 2+ doses, at least one during ANC visit 34.6 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2015-16 DHS 4167 4219      
669 249225 SP/Fansidar 3+ doses, at least one during ANC visit 7.7 1 TZ Tanzania 2015 TZ2015DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2015-16 DHS 4167 4219      
670 73655 SP/Fansidar use during pregnancy 83.1 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2017 MIS 2947 3068      
671 73656 SP/Fansidar 2+ doses during pregnancy 56.1 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2017 MIS 2947 3068      
672 73660 SP/Fansidar 3+ doses during pregnancy 25.8 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2017 MIS 2947 3068      
673 73657 SP/Fansidar use during antenatal visit 81.4 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2017 MIS 2947 3068      
674 73658 SP/Fansidar 2+ doses, at least one during ANC visit 55.4 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2017 MIS 2947 3068      
675 73659 SP/Fansidar 3+ doses, at least one during ANC visit 25.5 1 TZ Tanzania 2017 TZ2017MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2017 MIS 2947 3068      
676 399848 SP/Fansidar use during pregnancy 79.2 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2022 DHS 4335 4308      
677 399852 SP/Fansidar 2+ doses during pregnancy 58.4 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2022 DHS 4335 4308      
678 399851 SP/Fansidar 3+ doses during pregnancy 31.7 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2022 DHS 4335 4308      
679 399854 SP/Fansidar use during antenatal visit 74.6 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2022 DHS 4335 4308      
680 399855 SP/Fansidar 2+ doses, at least one during ANC visit 55.2 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2022 DHS 4335 4308      
681 399856 SP/Fansidar 3+ doses, at least one during ANC visit 30 1 TZ Tanzania 2022 TZ2022DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2022 DHS 4335 4308      
682 646461 SP/Fansidar use during pregnancy 36.6 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2006 DHS 3247 3239      
683 646462 SP/Fansidar 2+ doses during pregnancy 17.6 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2006 DHS 3247 3239      
684 646466 SP/Fansidar 3+ doses during pregnancy 6.1 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2006 DHS 3247 3239      
685 646463 SP/Fansidar use during antenatal visit 33.5 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2006 DHS 3247 3239      
686 646464 SP/Fansidar 2+ doses, at least one during ANC visit 16.2 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2006 DHS 3247 3239      
687 646465 SP/Fansidar 3+ doses, at least one during ANC visit 5.7 1 UG Uganda 2006 UG2006DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2006 DHS 3247 3239      
688 137706 SP/Fansidar use during pregnancy 46.6 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2009 MIS 1464 1506      
689 137707 SP/Fansidar 2+ doses during pregnancy 32.5 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2009 MIS 1464 1506      
690 137708 SP/Fansidar 3+ doses during pregnancy 17 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2009 MIS 1464 1506      
691 137720 SP/Fansidar use during antenatal visit 44.7 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2009 MIS 1464 1506      
692 137721 SP/Fansidar 2+ doses, at least one during ANC visit 31.7 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2009 MIS 1464 1506      
693 137722 SP/Fansidar 3+ doses, at least one during ANC visit 16.5 1 UG Uganda 2009 UG2009MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2009 MIS 1464 1506      
694 250634 SP/Fansidar use during pregnancy 48.4 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2011 DHS 3092 3019      
695 250635 SP/Fansidar 2+ doses during pregnancy 26.7 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2011 DHS 3092 3019      
696 250633 SP/Fansidar 3+ doses during pregnancy 10.3 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2011 DHS 3092 3019      
697 250636 SP/Fansidar use during antenatal visit 44.9 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2011 DHS 3092 3019      
698 250650 SP/Fansidar 2+ doses, at least one during ANC visit 24.5 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2011 DHS 3092 3019      
699 250651 SP/Fansidar 3+ doses, at least one during ANC visit 9.4 1 UG Uganda 2011 UG2011DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2011 DHS 3092 3019      
700 108654 SP/Fansidar use during pregnancy 64.3 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2014-15 MIS 1820 1799      
701 108655 SP/Fansidar 2+ doses during pregnancy 48.9 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2014-15 MIS 1820 1799      
702 108652 SP/Fansidar 3+ doses during pregnancy 27.5 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2014-15 MIS 1820 1799      
703 108656 SP/Fansidar use during antenatal visit 59.3 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2014-15 MIS 1820 1799      
704 108651 SP/Fansidar 2+ doses, at least one during ANC visit 45.2 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2014-15 MIS 1820 1799      
705 108653 SP/Fansidar 3+ doses, at least one during ANC visit 25.2 1 UG Uganda 2014 UG2014MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2014-15 MIS 1820 1799      
706 251431 SP/Fansidar use during pregnancy 78.5 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2016 DHS 5901 5992      
707 251432 SP/Fansidar 2+ doses during pregnancy 45.9 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2016 DHS 5901 5992      
708 251430 SP/Fansidar 3+ doses during pregnancy 17.2 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2016 DHS 5901 5992      
709 251433 SP/Fansidar use during antenatal visit 76.9 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2016 DHS 5901 5992      
710 251436 SP/Fansidar 2+ doses, at least one during ANC visit 45 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2016 DHS 5901 5992      
711 251437 SP/Fansidar 3+ doses, at least one during ANC visit 16.8 1 UG Uganda 2016 UG2016DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2016 DHS 5901 5992      
712 593593 SP/Fansidar use during pregnancy 89 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018-19 MIS 2481 2635      
713 593594 SP/Fansidar 2+ doses during pregnancy 72.1 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018-19 MIS 2481 2635      
714 593626 SP/Fansidar 3+ doses during pregnancy 41 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018-19 MIS 2481 2635      
715 593595 SP/Fansidar use during antenatal visit 88.2 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018-19 MIS 2481 2635      
716 593596 SP/Fansidar 2+ doses, at least one during ANC visit 71.7 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018-19 MIS 2481 2635      
717 593598 SP/Fansidar 3+ doses, at least one during ANC visit 40.6 1 UG Uganda 2018 UG2018MIS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018-19 MIS 2481 2635      
718 723708 SP/Fansidar use during pregnancy 0.7 1 ZM Zambia 2002 ZM2002DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2001-02 DHS 2667 2769      
719 723709 SP/Fansidar use during antenatal visit 0.4 1 ZM Zambia 2002 ZM2002DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2001-02 DHS 2667 2769      
720 483134 SP/Fansidar use during pregnancy 86.8 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2007 DHS 2631 2615      
721 483135 SP/Fansidar 2+ doses during pregnancy 65.7 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2007 DHS 2631 2615      
722 483133 SP/Fansidar 3+ doses during pregnancy 43.1 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2007 DHS 2631 2615      
723 483136 SP/Fansidar use during antenatal visit 82.4 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2007 DHS 2631 2615      
724 483158 SP/Fansidar 2+ doses, at least one during ANC visit 62.5 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2007 DHS 2631 2615      
725 483159 SP/Fansidar 3+ doses, at least one during ANC visit 40.9 1 ZM Zambia 2007 ZM2007DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2007 DHS 2631 2615      
726 252002 SP/Fansidar use during pregnancy 92.1 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2013-14 DHS 5074 5096      
727 252003 SP/Fansidar 2+ doses during pregnancy 75.5 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2013-14 DHS 5074 5096      
728 252030 SP/Fansidar 3+ doses during pregnancy 51.4 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2013-14 DHS 5074 5096      
729 252004 SP/Fansidar use during antenatal visit 88.4 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2013-14 DHS 5074 5096      
730 252005 SP/Fansidar 2+ doses, at least one during ANC visit 72.7 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2013-14 DHS 5074 5096      
731 252029 SP/Fansidar 3+ doses, at least one during ANC visit 49.6 1 ZM Zambia 2013 ZM2013DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2013-14 DHS 5074 5096      
732 252063 SP/Fansidar use during pregnancy 94 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2018 DHS 3905 3958      
733 252064 SP/Fansidar 2+ doses during pregnancy 81 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2018 DHS 3905 3958      
734 252069 SP/Fansidar 3+ doses during pregnancy 58.7 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2018 DHS 3905 3958      
735 252065 SP/Fansidar use during antenatal visit 93.7 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2018 DHS 3905 3958      
736 252066 SP/Fansidar 2+ doses, at least one during ANC visit 80.8 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2018 DHS 3905 3958      
737 252067 SP/Fansidar 3+ doses, at least one during ANC visit 58.6 1 ZM Zambia 2018 ZM2018DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2018 DHS 3905 3958      
738 673992 SP/Fansidar use during pregnancy 12.1 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2005-06 DHS 2144 2132      
739 673993 SP/Fansidar 2+ doses during pregnancy 6.8 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2005-06 DHS 2144 2132      
740 673996 SP/Fansidar 3+ doses during pregnancy 4.1 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2005-06 DHS 2144 2132      
741 673994 SP/Fansidar use during antenatal visit 11.2 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2005-06 DHS 2144 2132      
742 673995 SP/Fansidar 2+ doses, at least one during ANC visit 6.3 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2005-06 DHS 2144 2132      
743 673997 SP/Fansidar 3+ doses, at least one during ANC visit 3.8 1 ZW Zimbabwe 2005 ZW2005DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2005-06 DHS 2144 2132      
744 483959 SP/Fansidar use during pregnancy 13.9 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_SPF 124903010 I 1000 0 Total Total 0   1 1 MLIPTPWSPF   2010-11 DHS 2448 2437      
745 483960 SP/Fansidar 2+ doses during pregnancy 7.8 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_2SP 124903020 I 1000 0 Total Total 0   1 1 MLIPTPW2SP   2010-11 DHS 2448 2437      
746 483918 SP/Fansidar 3+ doses during pregnancy 5 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_3SP 124903025 I 1000 0 Total Total 0   1 1 MLIPTPW3SP   2010-11 DHS 2448 2437      
747 483961 SP/Fansidar use during antenatal visit 13.3 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_SPA 124903030 I 1000 0 Total Total 0   1 1 MLIPTPWSPA   2010-11 DHS 2448 2437      
748 483962 SP/Fansidar 2+ doses, at least one during ANC visit 7.3 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_2SA 124903040 I 1000 0 Total Total 0   1 1 MLIPTPW2SA   2010-11 DHS 2448 2437      
749 483963 SP/Fansidar 3+ doses, at least one during ANC visit 4.8 1 ZW Zimbabwe 2010 ZW2010DHS ML_IPTP_W_3SA 124903050 I 1000 0 Total Total 0   1 1 MLIPTPW3SA   2010-11 DHS 2448 2437      
<<Previous Next>>